HSP90 inhibitor NVP-BEP800 affects stability of SRC kinases and growth of T-cell and B-cell acute lymphoblastic leukemias

T-cell and B-cell acute lymphoblastic leukemias (T-ALL, B-ALL) are aggressive hematological malignancies characterized by an accumulation of immature T- or B-cells. Although patient outcomes have improved, novel targeted therapies are needed to reduce the intensity of chemotherapy and improve the pr...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Blood Cancer J
Glavni autori: Mshaik, Rony, Simonet, John, Georgievski, Aleksandra, Jamal, Layla, Bechoua, Shaliha, Ballerini, Paola, Bellaye, Pierre-Simon, Mlamla, Zandile, Pais de Barros, Jean-Paul, Geissler, Audrey, Francin, Pierre-Jean, Girodon, François, Garrido, Carmen, Quéré, Ronan
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2021
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7973815/
https://ncbi.nlm.nih.gov/pubmed/33737511
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-021-00450-2
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items